Alpha Circle Nsukka | Charts, Psychology & Market Discussions

P
@promisefx - 4 hours ago
Quoted - mitchei_1

Rubrik falls despite higher price target — RBRK dropped roughly 7% toward $91 even after Wells Fargo raised its price target to $120. Investors remain cautious ahead of Rubrik's fiscal Q2 results later this week.

That’s a clear sign investors are focused more on near-term execution than analyst upgrades. With earnings coming up, the guidance and growth outlook will likely be the real catalyst for RBRK.

P
@promisefx - 4 hours ago
Quoted - mitchei_1

Intuit becomes a major earnings focus — INTU was under heavy investor scrutiny ahead of its quarterly results. The stock has already fallen substantially this year as investors question how AI could disrupt traditional software businesses.

INTU is definitely one to watch. The key question is whether AI becomes a major threat to its core software business or a tool that actually strengthens its products and margins. Earnings guidance and management’s AI strategy could be just as important as the headline numbers.

P
@promisefx - 4 hours ago
Quoted - mitchei_1

Dick's Sporting Goods tumbles after outlook cut — DICK shares suffered a major decline after the retailer lowered its forecasts. Weakness in athletic footwear was cited as an important factor behind the disappointing outlook.

A sharp drop in DICK makes sense here. The lowered outlook signals that management expects weaker demand than previously anticipated, while softness in athletic footwear is particularly concerning because it’s a core category for the retailer.

The key question now is whether this is a temporary slowdown or evidence of a broader consumer pullback. If margins and sales guidance continue to deteriorate, investors could remain cautious even after the initial selloff.

P
@promisefx - 3 hours ago
Quoted - mitchei_1

Moderna surges on cancer-vaccine update — Moderna shares jumped after positive developments surrounding its cancer-vaccine trial with Merck. The news provided a major boost to the biotechnology stock while broader markets remained focused on technology.

Big move for MRNA 🚀 Positive cancer-vaccine data with Merck could be a major catalyst for Moderna. Now the focus shifts to whether this momentum can translate into strong late-stage results and long-term value.

P
@promisefx - 3 hours ago
Quoted - mitchei_1

What's more likely to destroy a trader: a big loss or a big win?

Okay this is a good question but win or loss doesn't directly destroys a trader it's their actions after it, their actions towards win or loss or how they feel could potentially destroy them

For instance now when a trade pass a challenge phases and become funded, now this stage he hasn't gotten any payout from the firm but because he has become funded he feels that he's unstoppable, he feels hw has mastered it all, he feels he can never go wrong again, then booom he lost the account now he becomes depressed and never want to try again he will find it difficult to trust his self and his system

So you see?

P
@promisefx - 3 hours ago
Quoted - mitchei_1

Would you stop trading for the day after hitting your daily profit target, even if the market is still giving perfect setups?

Fr me it's depends on traders, the type of trader you are if my setup shows up I will take it regardless

P
@promisefx - 3 hours ago

Now those that don't understand this are term in stock, indices, commodity just like the oil

This are news on the reasons behind how they are being traded or how they react to some certain news event

Disclaimer:

At MyTradingLand.com, we connect you with forex brokers and provide a community for traders. While we offer valuable information and resources, please note that we are not financial advisors and cannot provide personalized financial advice. Always conduct your own research and invest responsibly.

Community Guidelines: The MyTradingLand.com community is designed as a resource for forex traders, promoting respectful and constructive discussions. We reserve the right to remove any content that is misleading, abusive, or violates our terms of service.

Broker Information: While we may receive commissions or advertising income from some of the brokers listed, this does not imply an endorsement of any broker, nor does it affect our review process. Our evaluations are based solely on objective criteria and user feedback.

Always verify the regulatory status of any broker with your local financial authority, along with their terms and privacy policies, before engaging with them. It is crucial to conduct thorough research to ensure that you are making informed decisions.

Risk Warning: At MyTradingLand.com, we strive to provide accurate information; however, the forex market is highly volatile and can change rapidly. It is essential to verify any information before making investment decisions.

Please be aware that trading in forex involves substantial risk, and it is possible to lose more than your trading equity/investment capital. 70-90% of retail CFD traders incur losses in their trading activities as per information from various brokers.

You are solely responsible for your use of MyTradingLand.com and any trading decisions you make. We encourage all users to educate themselves thoroughly about forex trading and to consider seeking advice from qualified financial professionals.

Advertising Disclosure: We may earn commissions from recommended brokers, but our reviews are independent (not influenced by potential earnings). Sponsored content is clearly marked and doesn't reflect our views.

©2026 ©2025 All rights reserved Mytradingland.com